Education
About Us
Working with TipRanks
Follow Us
Nanobiotix SA (FR:NANO)
:NANO
Total Valuation
Nanobiotix has a market cap or net worth of €202.61M. The enterprise value is €196.91M.
Market Cap€202.61M
Enterprise Value€196.91M
Share Statistics
Nanobiotix has 47,133,327 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,133,327
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nanobiotix’s return on equity (ROE) is 1.04 and return on invested capital (ROIC) is -510.92%.
Return on Equity (ROE)1.04
Return on Assets (ROA)-1.01
Return on Invested Capital (ROIC)-510.92%
Return on Capital Employed (ROCE)-8.06
Revenue Per Employee-107.49K
Profits Per Employee-630.85K
Employee Count108
Asset Turnover-0.17
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nanobiotix is -2.10. Nanobiotix’s PEG ratio is -0.19.
PE Ratio-2.10
PS Ratio0.00
PB Ratio-2.98
Price to Fair Value-2.17
Price to FCF-127.86
Price to Operating Cash Flow-188.81
PEG Ratio-0.19
Income Statement
In the last 12 months, Nanobiotix had revenue of -11.61M and earned -68.13M in profits. Earnings per share was -1.44.
Revenue-11.61M
Gross Profit-11.61M
Operating Income-68.39M
Pretax Income-68.03M
Net Income-68.13M
EBITDA-61.62M
Earnings Per Share (EPS)-1.44
Cash Flow
In the last 12 months, operating cash flow was -19.55M and capital expenditures -846.00K, giving a free cash flow of -20.40M billion.
Operating Cash Flow-19.55M
Free Cash Flow-20.40M
Free Cash Flow per Share-0.43
Dividends & Yields
Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.44
52-Week Price Change-10.50%
50-Day Moving Average3.28
200-Day Moving Average3.61
Relative Strength Index (RSI)79.69
Average Volume (3m)130.57K
Important Dates
Nanobiotix upcoming earnings date is Sep 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateSep 4, 2025
Ex-Dividend Date―
Financial Position
Nanobiotix as a current ratio of 1.04, with Debt / Equity ratio of -77.47%
Current Ratio1.04
Quick Ratio1.04
Debt to Market Cap0.33
Net Debt to EBITDA-0.02
Interest Coverage Ratio-8.46
Taxes
In the past 12 months, Nanobiotix has paid 101.00K in taxes.
Income Tax101.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Nanobiotix EV to EBITDA ratio is -2.34, with an EV/FCF ratio of -7.05.
EV to Sales-12.40
EV to EBITDA-2.34
EV to Free Cash Flow-7.05
EV to Operating Cash Flow-7.36
Balance Sheet
Nanobiotix has €49.74M in cash and marketable securities with €50.90M in debt, giving a net cash position of €1.17M billion.
Cash & Marketable Securities€49.74M
Total Debt€50.90M
Net Cash€1.17M
Net Cash Per Share€0.02
Tangible Book Value Per Share-€1.39
Margins
Gross margin is 106.77%, with operating margin of 589.13%, and net profit margin of 586.89%.
Gross Margin106.77%
Operating Margin589.13%
Pretax Margin586.02%
Net Profit Margin586.89%
EBITDA Margin530.83%
EBIT Margin516.37%
Analyst Forecast
The average price target for Nanobiotix is €13.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€13.50
Price Target Upside213.95% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast56.18%